COMPANY

VisionGate

HQ: Bothell, WA source · visiongate3d.com ↗ · Southwest

Keywords: oncology

Location: Bothell, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 6

Annual award amounts. Total $3.5M.

Aug 5, 2011 NIH award 1R43HL107040-01A1 FY2011: $159,849 awarded for that fiscal year; activity R43 (SBIR); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., PHOENIX, AZ. Development of an Advanced In-Vitro Model for A source ↗
Jun 18, 2010 NIH award 1RC3GM093818-01 FY2010: $2,621,703 awarded for that fiscal year; activity RC3 (OTHER_NIH); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., PHOENIX, AZ. Development of high-throughput, commercial source ↗
Jun 11, 2010 NIH award 1R43CA144469-01 FY2010: $164,091 awarded for that fiscal year; activity R43 (SBIR); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., PHOENIX, AZ. Development of a Vascularized In-Vitro Model of t source ↗
Mar 18, 2010 NIH award 1R43NS070440-01 FY2010: $190,632 awarded for that fiscal year; activity R43 (SBIR); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., PHOENIX, AZ. Development of an organotypic in-vitro model of t source ↗
Aug 29, 2006 NIH award 5R21HL081152-02 FY2006: $160,342 awarded for that fiscal year; activity R21 (OTHER_NIH); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., GIG HARBOR, WA. Development of an In-Vitro Angiogenesis S source ↗
Sep 2, 2005 NIH award 1R21HL081152-01 FY2005: $199,200 awarded for that fiscal year; activity R21 (OTHER_NIH); PI NEUMANN, THOMAS; recipient as written: VISIONGATE, INC., GIG HARBOR, WA. Development of an In-Vitro Angiogenesis S source ↗